NBIX
Price
$140.44
Change
+$2.04 (+1.47%)
Updated
Sep 28 closing price
Capitalization
14.07B
35 days until earnings call
Intraday BUY SELL Signals
QMID
Price
$28.76
Change
-$0.27 (-0.93%)
Updated
Sep 28 closing price
Net Assets
2.18M
Intraday BUY SELL Signals
Interact to see
Advertisement

NBIX vs QMID

NBIX vs QMID Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NBIX vs. QMID commentary
Sep 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBIX is a Buy and QMID is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
NBIX: Fundamental Ratings
NBIX
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
44
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NBIXQMID
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 5 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 20 days ago
71%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
54%
Bearish Trend 6 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
65%
COMPARISON
Comparison
Sep 29, 2026
Stock price -- (NBIX: $140.44)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBIX’s FA Score shows that 0 FA rating(s) are green while .

  • NBIX’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBIX’s TA Score shows that 4 TA indicator(s) are bullish.

  • NBIX’s TA Score: 4 bullish, 3 bearish.

Price Growth

NBIX (@Pharmaceuticals: Generic) experienced а -2.45% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.95%. For the same industry, the average monthly price growth was -2.25%, and the average quarterly price growth was +37.53%.

Reported Earning Dates

NBIX is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.95% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
NBIX
Daily Signal:
Gain/Loss:
QMID
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTRN50.821.79
+3.65%
Citi Trends
BLX54.970.23
+0.42%
Bladex Inc
CHPGU10.59N/A
N/A
Championsgate Acquisition Corp
SCI77.07-0.77
-0.99%
Service Corp
BOLD2.61-0.05
-1.88%
Boundless Bio

QMID and

Correlation & Price change

A.I.dvisor indicates that over the last year, QMID has been loosely correlated with CSW. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if QMID jumps, then CSW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QMID
1D Price
Change %
QMID100%
-0.92%
CSW - QMID
41%
Loosely correlated
-0.47%
SYM - QMID
15%
Poorly correlated
-3.38%
CELH - QMID
15%
Poorly correlated
+0.04%
THC - QMID
14%
Poorly correlated
-0.69%
NBIX - QMID
12%
Poorly correlated
+1.47%
More